<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The role of imaging tests in the evaluation of anal abscesses and fistulas</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The role of imaging tests in the evaluation of anal abscesses and fistulas</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">The role of imaging tests in the evaluation of anal abscesses and fistulas</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David A Schwartz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Maurits J Wiersema, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Perianal fistulas and abscesses are among the most serious manifestations of Crohn disease and non-Crohn related anorectal disease  (<a class="graphic graphic_picture graphicRef78460" href="/d/graphic/78460.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef67524" href="/d/graphic/67524.html" rel="external">picture 2</a>). Complications can lead to difficulties with recurrent or non-healing fistulas or abscesses. In addition, these patients are at risk of incontinence as a result of the destructive nature of the fistulizing process and/or inadvertent damage to the anal sphincters during surgical exploration.</p><p>The lifetime risk for developing a fistula in patients with Crohn disease is 20 to 40 percent [<a href="#rid1">1-4</a>]. The frequency of perianal fistulas/abscesses in patients without Crohn disease has not been well established, but in a telephone survey of 102 randomly selected individuals, 20 percent of the individuals contacted had perianal symptoms (hemorrhoids, fistulas, etc) [<a href="#rid5">5</a>]. Despite the significant prevalence of perianal disease, the evaluation of this problem was, in the past, largely limited to digital rectal examination.</p><p>The inability of the clinician to directly visualize the fistula or abscess makes it difficult to assess the lesions. The clinician must essentially discern the perianal anatomy by touch. This task is made even more problematic by the induration and inflammation that is usually present in these patients. Even surgical evaluation is only 35 to 85 percent accurate when compared with the results of other diagnostic tests and clinical evaluation [<a href="#rid6">6-9</a>].</p><p>The importance of accurately characterizing the perianal process prior to embarking on therapy cannot be overemphasized. The risk of incomplete healing, a recurrent fistula, or even inadvertent sphincter injury is increased if fistula anatomy is incorrectly delineated or an occult abscess missed. An imaging modality should ideally provide a virtual road map that the clinician can use to plan therapy. This is especially true with fistulas that involve a significant portion of the anal sphincter complex. Such patients are at the greatest risk of developing incontinence from the destructive fistulizing process or from overly aggressive surgical treatment.</p><p>Thus, patients with simple fistulas that only involve a small portion or none of the external anal sphincter generally do well with either medical or surgical treatment. Imaging of the fistula is helpful in determining the type of fistula to guide treatment but is not always needed. By contrast, for patients with a complex fistula (ie, one that involves a significant portion of the sphincter complex), preoperative imaging is mandatory.</p><p>Several imaging modalities are available to evaluate perianal fistulas and abscesses. These include fistulography, computed tomography, magnetic resonance imaging, and ultrasonography (both transrectal and endoscopic). The efficacy of each modality (with emphasis on endoscopic ultrasonography) will be reviewed here.</p><p class="headingAnchor" id="H2"><span class="h1">FISTULOGRAPHY</span><span class="headingEndMark"> — </span>Fistulography has traditionally been the primary method of evaluating perianal fistulas. It involves insertion of a small caliber catheter into the external opening of a fistula and injection of radiographic contrast material directly into the fistula track. Radiographs from different angles are then obtained.</p><p>Fistulography has several drawbacks. The crucial determination of the fistula's course in relation to the sphincter complex must be inferred because the musculature of the anorectum cannot be visualized. In addition, instillation of the contrast material can be painful and can lead to the theoretical dissemination of septic fistulous contents.</p><p>Furthermore, the accuracy of fistulography has been questioned. In one retrospective study of 25 patients, the findings of fistulography were compared with the operative findings [<a href="#rid10">10</a>]. Fistulograms were correct in only four patients (16 percent). In addition, false-positive results that could have led to unnecessary complications occurred in three patients (12 percent).</p><p>As a result of these limitations, fistulography should generally be reserved for select patients in whom there is concern about a fistulous connection between the rectum and an adjacent organ such as the bladder.</p><p class="headingAnchor" id="H3"><span class="h1">COMPUTED TOMOGRAPHY</span><span class="headingEndMark"> — </span>Computed tomography (CT) permits structures outside of the bowel lumen to be visualized, an advantage compared with fistulography. It is valuable for evaluating suspected perianal abscesses and inflammation [<a href="#rid11">11-15</a>]. In one study, for example, CT (with intravenous and, when possible, rectal contrast) was useful in differentiating perirectal abscesses from severe perirectal cellulitis and correctly identified 13 surgical proven abscesses in 10 patients [<a href="#rid16">16</a>].</p><p>The utility of CT for perianal fistulas is less clear. Fistulas are identified on CT when either a linear track containing air or contrast material is demonstrated extending from the bowel. The limited resolution of CT makes it difficult to differentiate between inflammatory soft tissue streaking and a fistula tract [<a href="#rid15">15</a>]. One study of 25 patients with suspected perianal Crohn disease compared the efficacy of endoscopic ultrasound (EUS) and CT [<a href="#rid17">17</a>]. EUS was conducted using a 5 MHz radial scanning scope. CT was performed using both intravenous and rectal contrast. Results were compared with findings at surgery and/or clinical course. EUS was found to be more accurate than CT in the evaluation of perianal fistulas (82 versus 24 percent).</p><p>Another limitation of CT is that the classification of fistulas can be difficult because CT scans in the transverse plane make the identification of the levator ani unreliable [<a href="#rid16">16</a>]. Because of these reasons, and because CT exposes the patient to ionizing radiation, the use of CT in these patients is limited.</p><p class="headingAnchor" id="H4"><span class="h1">MAGNETIC RESONANCE IMAGING</span><span class="headingEndMark"> — </span>Because of the limitations of fistulography and computed tomography (CT), attention has turned to the newer technologies, such as magnetic resonance imaging (MRI)  (<a class="graphic graphic_diagnosticimage graphicRef72435" href="/d/graphic/72435.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef50476" href="/d/graphic/50476.html" rel="external">image 2</a>) and ultrasound, as a better means of imaging perianal fistulas. Several prospective studies have looked at MRI in the evaluation of fistula-in-ano in patients without Crohn disease. Most of these studies used examination under anesthesia as the gold standard [<a href="#rid8">8,18,19</a>]. Two of the largest studies had widely differing results. In one, the results of MRI were compared with surgical evaluation in 35 patients [<a href="#rid20">20</a>]. The overall concordance between MRI and surgery was 85 percent. In contrast, using similar methodology, the group from University Hospital Nottingham reported accuracy of MRI in 33 patients to be only 42 percent [<a href="#rid18">18</a>].</p><p>However, at least three studies have questioned the use of surgical evaluation as a gold standard [<a href="#rid7">7,9,21</a>]. Patients were followed postoperatively to allow time for a missed fistula or abscess to declare itself, thereby permitting determination of the predictive value of MRI and examination under anesthesia. In one study of 42 patients MRI was found to be more sensitive than examination under anesthesia (95 versus 76 percent) [<a href="#rid21">21</a>]. Another series of 40 patients who were followed for 14 months postoperatively found a sensitivity and specificity of 89 and 69 percent, respectively, for MRI compared with 73 and 47 percent, respectively, for surgical exploration [<a href="#rid7">7</a>]. An updated report of 52 patients from the same group found MRI to be slightly more sensitive than surgical assessment in determining disease severity (81 versus 77 percent), although these results were not statistically significant [<a href="#rid9">9</a>].</p><p>Only a few studies have looked at MRI utility specifically in patients with Crohn disease with perianal fistulas:</p><p class="bulletIndent1"><span class="glyph">●</span>In a pilot study, MRI was able to identify eight out of nine (89 percent) perianal fistulas [<a href="#rid22">22</a>]. However, this study used unreliable imaging modalities such as CT and fistulography as the gold standard. Five years later, the same group found MRI to be 86 percent sensitive in delineating perianal fistula anatomy in 34 Crohn patients using surgical findings as the gold standard [<a href="#rid23">23</a>]. MRI seemed to have more difficulty demonstrating the shorter, more superficial tracks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One of the largest studies included 54 patients with suspected perianal Crohn disease [<a href="#rid24">24</a>]. The authors reviewed the proctological, MRI, and intraoperative findings to determine a consensus gold standard that they used as their benchmark. A total of 90 fistulas and 83 abscesses were found in these patients. MRI was 82 percent accurate for determining fistula anatomy, and, as in the previous report [<a href="#rid23">23</a>], tended to miss the short or superficial fistula tracks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another report focused on 18 patients who were studied before and after treatment with <a class="drug drug_general" data-topicid="8984" href="/d/drug information/8984.html" rel="external">infliximab</a> [<a href="#rid25">25</a>]. A fistula track with signs of active inflammation was visualized with MRI in all patients prior to therapy. The fistula track remained visible in 8 of 11 patients who responded clinically to infliximab. After long-term treatment (46 weeks), MRI signs of active track inflammation had resolved in three of six patients. These findings suggest that despite closure of draining external orifices following infliximab therapy, fistula tracks can persist with varying degrees of inflammation. Similar findings have been described by others using both MRI and endosonography [<a href="#rid26">26-29</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">ENDOSONOGRAPHY</span><span class="headingEndMark"> — </span>Endosonography, both blind transrectal (TRUS) and endoscopic ultrasound (EUS), has also been used to evaluate perianal fistulas. Similar to the magnetic resonance imaging (MRI) literature, the vast majority of the ultrasound studies have focused on patients without Crohn disease.</p><p class="headingAnchor" id="H6"><span class="h2">Technical aspects</span><span class="headingEndMark"> — </span>Two discrete rings of tissue can be seen when using a radial scanning echoendoscope to examine the anorectum  (<a class="graphic graphic_diagnosticimage graphicRef56203" href="/d/graphic/56203.html" rel="external">image 3</a>). The inner hypoechoic ring of tissue represents the internal anal sphincter, which is formed by the thickened continuation of the circular smooth muscle of the rectum. It is usually approximately 3 cm in length. The outer hyperechoic ring of tissue represents the external anal sphincter, which is formed by the downward extension of the skeletal muscle of the puborectalis. It is generally 4 cm in length.</p><p>The initial endosonographic studies used 7 MHz radial probes that were placed blindly into the rectum. These early pilot studies yielded promising results with the sensitivity for visualizing anal fistulas greater than 90 percent [<a href="#rid30">30,31</a>]. Several centers have tried to increase the sensitivity of ultrasound by instilling <a class="drug drug_general" data-topicid="113931" href="/d/drug information/113931.html" rel="external">hydrogen peroxide</a> into the fistula tracks [<a href="#rid32">32,33</a>]. Hydrogen peroxide acts as a contrast medium for ultrasound, creating echo-rich bubbles within the fistula track. This method is limited to fistulas with cutaneous openings. A limitation of this approach is that hydrogen peroxide can cause acoustic shadowing that may lead to misinterpretation of the fistula track. In our experience, a 7 MHz linear scanning ultrasound probe is able to clearly demonstrate the air within a fistula tract, thus making instillation of hydrogen peroxide unnecessary  (<a class="graphic graphic_diagnosticimage graphicRef56772" href="/d/graphic/56772.html" rel="external">image 4</a>). Frequently, by applying gentle pressure to the fistula tract with the linear probe we can clearly visualize the air bubble moving within the tract itself  (<a class="graphic graphic_movie graphicRef78768" href="/d/graphic/78768.html" rel="external">movie 1</a>).</p><p class="headingAnchor" id="H7"><span class="h2">Accuracy</span><span class="headingEndMark"> — </span>In one of the more commonly quoted TRUS studies in the literature, the group from St. Mark's reported disappointing results using TRUS to evaluate fistula-in-ano [<a href="#rid6">6</a>]. In this prospective study of 38 patients with suspected fistula-in-ano, digital rectal examination by an experienced consultant was compared with TRUS. Surgical findings were considered the gold standard. Digital rectal exam (DRE) was found to be more accurate than ultrasound in determining the course of the primary fistula track (85 percent versus 72 percent).</p><p>However, these results must be interpreted with caution for several reasons. The difference between DRE and TRUS did not meet statistical significance. In addition, as the authors readily admit, the rigid nature of the probe prevented good acoustic coupling higher in the rectum, thus preventing the interpretation of higher fistula tracks. Furthermore, the focal length of the probe utilized for this study was only 3 cm, which limited scanning to no deeper than the external anal sphincter (EAS). To prevent these problems, we use an inflatable balloon probe on a flexible echoendoscope to permit better acoustic coupling throughout the rectum. In addition, we evaluate the fistulas with both radial and linear scanning instruments in order to achieve a greater depth of imaging and to more thoroughly characterize the fistulas.</p><p>The destructive and recurrent nature of perianal Crohn disease makes accurate imaging more difficult than with simple fistula-in-ano. However, several non-blinded studies have shown ultrasound to be a viable modality for examining the perianal manifestations of Crohn disease [<a href="#rid34">34-39</a>]. A prospective blinded study compared EUS with computed tomography (CT) in 25 Crohn patients with suspected perianal involvement [<a href="#rid17">17</a>]. A 5 MHz radial scanning probe was used to conduct the ultrasound examinations. Surgery or fistulography was used as the gold standard. EUS was found to be superior to CT with a sensitivity of 82 versus 24 percent, respectively.</p><p>A later, randomized prospective study randomly assigned 10 patients with EUS with examination under anesthesia, or examination under anesthesia alone [<a href="#rid40">40</a>]. Patients were managed medically or surgically based upon the finding. At the end of one year, patients randomized to the EUS arm were more likely to have complete cessation of drainage, suggesting that the EUS may have improved care.</p><p>At least four prospective studies have compared MRI with endosonography in the evaluation of perianal fistulas [<a href="#rid20">20,41-43</a>]. Two of these reports concentrated exclusively on patients with Crohn disease [<a href="#rid42">42,43</a>]. The two studies focusing primarily on non-Crohn patients using surgery as the gold standard found MRI to be superior to TRUS in imaging fistulas [<a href="#rid20">20,41</a>]. Both of these studies used 7 MHz rigid radial scanning ultrasound probes. The limitation of this equipment (see <a class="local">'Technical aspects'</a> above) most likely contributed to the lower ultrasound sensitivity seen in these studies.</p><p>In contrast, one of the prospective studies comparing MRI and EUS for Crohn perianal fistulas found endosonography to be the most sensitive modality for imaging fistulas [<a href="#rid42">42</a>]. In this pilot study of 22 patients, surgical evaluation was used as the gold standard. The agreement for fistulas with the surgical findings for endosonography and MRI was 82 percent and 50 percent, respectively. Ultrasound was performed with a 7 MHz linear scanning probe. Although not used in this study, we also use a radial scanning probe to provide complimentary information. This can reveal fistulas not apparent with the linear probe  (<a class="graphic graphic_diagnosticimage graphicRef82082" href="/d/graphic/82082.html" rel="external">image 5</a>).</p><p>The poor sensitivity of MRI in this study (50 percent) may be secondary to the use of a body coil for imaging instead of a pelvic phased array coil. The pelvic phased array coil is a receive-only coil and provides better spatial resolution than is available with the body coil. A study using the phased array suggested that it was highly accurate in detecting primary tracks and secondary extensions and provided important additional information in 12 out of 56 patients (21 percent) enrolled in the study [<a href="#rid44">44</a>]. The benefit of MRI was most obvious in patients with fistulas related to Crohn disease and in patients with complex fistulas associated with a recurrence.</p><p>Similar conclusions were reached in another study in 34 patients with Crohn disease who were suspected of having perianal fistulas [<a href="#rid43">43</a>]. Patients underwent EUS and MRI within the same week followed by surgical examination under anesthesia (EUA). The gold standard anatomy was defined after reviewing data from all three modalities. All three methods demonstrated good agreement with the gold standard (EUS 91 percent, MRI 87 percent, and EUA 91 percent). The accuracy increased to 100 percent when EUA was combined with either EUS or MRI.</p><p>Several studies have evaluated EUS and MRI in monitoring the course of fistula healing in patients with perianal Crohn disease [<a href="#rid25">25,45-48</a>]. Two reports also suggested that treatment based upon EUS findings was helpful in determining the optimal time to remove a seton [<a href="#rid40">40,47</a>]. In addition, one prospective study utilizing MRI to monitor fistula healing in patients with Crohn perianal fistulas on anti-TNF treatment suggested that imaging may be useful in identifying patients who need continued medical therapy [<a href="#rid49">49</a>]. </p><p class="headingAnchor" id="H203862012"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/17210.html" rel="external">"Patient education: Anal abscess and fistula (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Perianal fistulas and abscesses are a common problem; proper therapy depends upon the accurate assessment of the perianal anatomy. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fistulography is <strong>not</strong> an accurate means of evaluating perianal disease. (See <a class="local">'Fistulography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Computed tomography (CT) may be helpful when looking for large intrapelvic abscesses. CT is inaccurate for the detection and classification of perianal fistula tracks and small perianal abscess collections. (See <a class="local">'Computed tomography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Magnetic resonance imaging (MRI) and endosonography <strong>are</strong> an accurate means of evaluating perianal disease, with an accuracy of approximately 80 to 90 percent compared with surgical exam under anesthesia. Accuracy of MRI depends upon availability of MRI imaging with dedicated pelvic coils. The dedicated pelvic coil provides better spatial resolution in the pelvis. Similarly, the accuracy of ultrasound depends upon achievement of good acoustic coupling by using water-filled inflatable balloons. (See <a class="local">'Magnetic resonance imaging'</a> above and <a class="local">'Endosonography'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21:525.</a></li><li><a class="nounderline abstract_t">Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68:627.</a></li><li><a class="nounderline abstract_t">Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77:914.</a></li><li><a class="nounderline abstract_t">Schwartz D, Loftus E, Tremaine W, et al. The natural history of fistulizing Crohn's disease: a population based study. Gastroenterology 2000; 118:A337.</a></li><li><a class="nounderline abstract_t">Nelson RL, Abcarian H, Davis FG, Persky V. Prevalence of benign anorectal disease in a randomly selected population. Dis Colon Rectum 1995; 38:341.</a></li><li><a class="nounderline abstract_t">Choen S, Burnett S, Bartram CI, Nicholls RJ. Comparison between anal endosonography and digital examination in the evaluation of anal fistulae. Br J Surg 1991; 78:445.</a></li><li><a class="nounderline abstract_t">Spencer JA, Chapple K, Wilson D, et al. Outcome after surgery for perianal fistula: predictive value of MR imaging. AJR Am J Roentgenol 1998; 171:403.</a></li><li><a class="nounderline abstract_t">Van Beers B, Grandin C, Kartheuser A, et al. MRI of complicated anal fistulae: comparison with digital examination. J Comput Assist Tomogr 1994; 18:87.</a></li><li><a class="nounderline abstract_t">Chapple KS, Spencer JA, Windsor AC, et al. Prognostic value of magnetic resonance imaging in the management of fistula-in-ano. Dis Colon Rectum 2000; 43:511.</a></li><li><a class="nounderline abstract_t">Kuijpers HC, Schulpen T. Fistulography for fistula-in-ano. Is it useful? Dis Colon Rectum 1985; 28:103.</a></li><li><a class="nounderline abstract_t">Fishman EK, Wolf EJ, Jones B, et al. CT evaluation of Crohn's disease: effect on patient management. AJR Am J Roentgenol 1987; 148:537.</a></li><li><a class="nounderline abstract_t">Goldberg HI, Gore RM, Margulis AR, et al. Computed tomography in the evaluation of Crohn disease. AJR Am J Roentgenol 1983; 140:277.</a></li><li><a class="nounderline abstract_t">Berliner L, Redmond P, Purow E, et al. Computed tomography in Crohn's disease. Am J Gastroenterol 1982; 77:548.</a></li><li><a class="nounderline abstract_t">Kerber GW, Greenberg M, Rubin JM. Computed tomography evaluation of local and extraintestinal complications of Crohn's disease. Gastrointest Radiol 1984; 9:143.</a></li><li><a class="nounderline abstract_t">Yousem DM, Fishman EK, Jones B. Crohn disease: perirectal and perianal findings at CT. Radiology 1988; 167:331.</a></li><li><a class="nounderline abstract_t">Guillaumin E, Jeffrey RB Jr, Shea WJ, et al. Perirectal inflammatory disease: CT findings. Radiology 1986; 161:153.</a></li><li><a class="nounderline abstract_t">Schratter-Sehn AU, Lochs H, Vogelsang H, et al. Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease. Endoscopy 1993; 25:582.</a></li><li><a class="nounderline abstract_t">Scholefield JH, Berry DP, Armitage NC, Wastie ML. Magnetic resonance imaging in the management of fistula in ano. Int J Colorectal Dis 1997; 12:276.</a></li><li><a class="nounderline abstract_t">Buchanan GN, Halligan S, Williams AB, et al. Magnetic resonance imaging for primary fistula in ano. Br J Surg 2003; 90:877.</a></li><li><a class="nounderline abstract_t">Lunniss PJ, Barker PG, Sultan AH, et al. Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum 1994; 37:708.</a></li><li><a class="nounderline abstract_t">Beckingham IJ, Spencer JA, Ward J, et al. Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging in the evaluation of fistula in ano. Br J Surg 1996; 83:1396.</a></li><li><a class="nounderline abstract_t">Koelbel G, Schmiedl U, Majer MC, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol 1989; 152:999.</a></li><li><a class="nounderline abstract_t">Skalej M, Makowiec F, Weinlich M, et al. [Magnetic resonance imaging in perianal Crohn's disease]. Dtsch Med Wochenschr 1993; 118:1791.</a></li><li><a class="nounderline abstract_t">Makowiec F, Laniado M, Jehle EC, et al. Magnetic resonance imaging in perianal Crohn's disease. Inflamm Bowel Dis 1995; 1:256.</a></li><li><a class="nounderline abstract_t">Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98:332.</a></li><li><a class="nounderline abstract_t">Bell SJ, Halligan S, Windsor AC, et al. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003; 17:387.</a></li><li><a class="nounderline abstract_t">Karmiris K, Bielen D, Vanbeckevoort D, et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 2011; 9:130.</a></li><li><a class="nounderline abstract_t">Rasul I, Wilson SR, MacRae H, et al. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Am J Gastroenterol 2004; 99:82.</a></li><li><a class="nounderline abstract_t">Ziech ML, Lavini C, Bipat S, et al. Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study. AJR Am J Roentgenol 2013; 200:W170.</a></li><li><a class="nounderline abstract_t">Deen KI, Williams JG, Hutchinson R, et al. Fistulas in ano: endoanal ultrasonographic assessment assists decision making for surgery. Gut 1994; 35:391.</a></li><li><a class="nounderline abstract_t">Law PJ, Talbot RW, Bartram CI, Northover JM. Anal endosonography in the evaluation of perianal sepsis and fistula in ano. Br J Surg 1989; 76:752.</a></li><li><a class="nounderline abstract_t">Cheong DM, Nogueras JJ, Wexner SD, Jagelman DG. Anal endosonography for recurrent anal fistulas: image enhancement with hydrogen peroxide. Dis Colon Rectum 1993; 36:1158.</a></li><li><a class="nounderline abstract_t">Poen AC, Felt-Bersma RJ, Eijsbouts QA, et al. Hydrogen peroxide-enhanced transanal ultrasound in the assessment of fistula-in-ano. Dis Colon Rectum 1998; 41:1147.</a></li><li><a class="nounderline abstract_t">el Mouaaouy A, Tolksdorf A, Starlinger M, Becker HD. [Endoscopic sonography of the anorectum in inflammatory rectal diseases]. Z Gastroenterol 1992; 30:486.</a></li><li><a class="nounderline abstract_t">Tio TL, Mulder CJ, Wijers OB, et al. Endosonography of peri-anal and peri-colorectal fistula and/or abscess in Crohn's disease. Gastrointest Endosc 1990; 36:331.</a></li><li><a class="nounderline abstract_t">Van Outryve MJ, Pelckmans PA, Michielsen PP, Van Maercke YM. Value of transrectal ultrasonography in Crohn's disease. Gastroenterology 1991; 101:1171.</a></li><li><a class="nounderline abstract_t">Solomon MJ. Fistulae and abscesses in symptomatic perianal Crohn's disease. Int J Colorectal Dis 1996; 11:222.</a></li><li><a class="nounderline abstract_t">Mulder C, Tio T, Tytgat G. Transrectal ultrasonography in the assessment of perianal fistula and/or abscess in Crohn's disease. Gastroenterology 1988; 94:A313.</a></li><li><a class="nounderline abstract_t">Schratter-Sehn AU, Lochs H, Handl-Zeller L, et al. Endosonographic features of the lower pelvic region in Crohn's disease. Am J Gastroenterol 1993; 88:1054.</a></li><li><a class="nounderline abstract_t">Spradlin NM, Wise PE, Herline AJ, et al. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Am J Gastroenterol 2008; 103:2527.</a></li><li><a class="nounderline abstract_t">Hussain SM, Stoker J, Schouten WR, et al. Fistula in ano: endoanal sonography versus endoanal MR imaging in classification. Radiology 1996; 200:475.</a></li><li><a class="nounderline abstract_t">Orsoni P, Barthet M, Portier F, et al. Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease. Br J Surg 1999; 86:360.</a></li><li><a class="nounderline abstract_t">Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121:1064.</a></li><li><a class="nounderline abstract_t">Beets-Tan RG, Beets GL, van der Hoop AG, et al. Preoperative MR imaging of anal fistulas: Does it really help the surgeon? Radiology 2001; 218:75.</a></li><li><a class="nounderline abstract_t">Ardizzone S, Maconi G, Colombo E, et al. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 2004; 10:91.</a></li><li><a class="nounderline abstract_t">van Bodegraven AA, Sloots CE, Felt-Bersma RJ, Meuwissen SG. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 2002; 45:39.</a></li><li><a class="nounderline abstract_t">Schwartz DA, White CM, Wise PE, Herline AJ. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Inflamm Bowel Dis 2005; 11:727.</a></li><li><a class="nounderline abstract_t">Tozer P, Ng SC, Siddiqui MR, et al. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 2012; 18:1825.</a></li><li><a class="nounderline abstract_t">Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am J Gastroenterol 2009; 104:2973.</a></li></ol></div><div id="topicVersionRevision">Topic 2580 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7429313" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1123132" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical patterns in Crohn's disease: a statistical study of 615 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/467943" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The natural history of fistulizing Crohn's disease: a population based study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7720437" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence of benign anorectal disease in a randomly selected population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2032103" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Comparison between anal endosonography and digital examination in the evaluation of anal fistulae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9694464" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Outcome after surgery for perianal fistula: predictive value of MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8282891" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : MRI of complicated anal fistulae: comparison with digital examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10789748" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prognostic value of magnetic resonance imaging in the management of fistula-in-ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3971802" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Fistulography for fistula-in-ano. Is it useful?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3492882" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : CT evaluation of Crohn's disease: effect on patient management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6600342" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Computed tomography in the evaluation of Crohn disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7102636" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Computed tomography in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6745591" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Computed tomography evaluation of local and extraintestinal complications of Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3357940" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Crohn disease: perirectal and perianal findings at CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3763858" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Perirectal inflammatory disease: CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8119208" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9401841" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Magnetic resonance imaging in the management of fistula in ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12854117" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Magnetic resonance imaging for primary fistula in ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8026238" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Magnetic resonance imaging of fistula-in-ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8944439" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging in the evaluation of fistula in ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2705359" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8253041" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : [Magnetic resonance imaging in perianal Crohn's disease].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23282424" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Magnetic resonance imaging in perianal Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12591051" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12562451" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21056696" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14687146" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23345381" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8150354" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Fistulas in ano: endoanal ultrasonographic assessment assists decision making for surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2670055" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Anal endosonography in the evaluation of perianal sepsis and fistula in ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8253014" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Anal endosonography for recurrent anal fistulas: image enhancement with hydrogen peroxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9749499" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hydrogen peroxide-enhanced transanal ultrasound in the assessment of fistula-in-ano.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1509788" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : [Endoscopic sonography of the anorectum in inflammatory rectal diseases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2210272" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Endosonography of peri-anal and peri-colorectal fistula and/or abscess in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1936786" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Value of transrectal ultrasonography in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8951512" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fistulae and abscesses in symptomatic perianal Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Transrectal ultrasonography in the assessment of perianal fistula and/or abscess in Crohn's disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8317405" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Endosonographic features of the lower pelvic region in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18684178" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8685344" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Fistula in ano: endoanal sonography versus endoanal MR imaging in classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201779" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11677197" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11152782" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Preoperative MR imaging of anal fistulas: Does it really help the surgeon?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15168807" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Perianal fistulae following infliximab treatment: clinical and endosonographic outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11786762" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16043987" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22223472" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Long-term MRI-guided combined anti-TNF-αand thiopurine therapy for Crohn's perianal fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19755971" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
